JPH11504940A - 胃腸障害の治療及び予防用のビスマス及び１以上の抗微生物剤含有組成物 - Google Patents

胃腸障害の治療及び予防用のビスマス及び１以上の抗微生物剤含有組成物

Info

Publication number
JPH11504940A
JPH11504940A JP8534218A JP53421896A JPH11504940A JP H11504940 A JPH11504940 A JP H11504940A JP 8534218 A JP8534218 A JP 8534218A JP 53421896 A JP53421896 A JP 53421896A JP H11504940 A JPH11504940 A JP H11504940A
Authority
JP
Japan
Prior art keywords
bismuth
administered
days
antimicrobial agents
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8534218A
Other languages
English (en)
Japanese (ja)
Inventor
アン フィッツジェラルド，ジャメシーナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPH11504940A publication Critical patent/JPH11504940A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8534218A 1995-05-09 1996-05-08 胃腸障害の治療及び予防用のビスマス及び１以上の抗微生物剤含有組成物 Pending JPH11504940A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43747595A 1995-05-09 1995-05-09
US08/437,475 1995-05-09
PCT/US1996/006489 WO1996035436A1 (en) 1995-05-09 1996-05-08 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
JPH11504940A true JPH11504940A (ja) 1999-05-11

Family

ID=23736610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8534218A Pending JPH11504940A (ja) 1995-05-09 1996-05-08 胃腸障害の治療及び予防用のビスマス及び１以上の抗微生物剤含有組成物

Country Status (6)

Country Link
EP (1) EP0830135A1 (de)
JP (1) JPH11504940A (de)
AU (1) AU5733696A (de)
CA (1) CA2219758A1 (de)
PE (1) PE48297A1 (de)
WO (1) WO1996035436A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2234581T3 (es) 1999-04-06 2005-07-01 Ethypharm Suspension farmaceutica bebible de ibuprofeno.
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222834A4 (de) * 1985-04-18 1989-10-04 Borody Thomas J Behandlung von nichtulcerativer dyspepsia mit wismutsalzen.
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
DE59309771D1 (de) * 1993-05-11 1999-10-14 Spirig Ag Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung

Also Published As

Publication number Publication date
WO1996035436A1 (en) 1996-11-14
CA2219758A1 (en) 1996-11-14
EP0830135A1 (de) 1998-03-25
PE48297A1 (es) 1998-02-04
AU5733696A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
JPH0794390B2 (ja) 胃腸疾患の治療のための医薬組成物
JP2733849B2 (ja) 胃腸障害治療のための改良された方法
US5256684A (en) Methods and compositions for the treatment of gastrointestinal disorders
KR960016582B1 (ko) 위장장해의 치료 및 예방용 약제학적 조성물
JPH06298768A (ja) ヘリコバクター・ピロリに起因する胃性消化不良を治療するためのリファキシミンを含有する医薬製剤
CN109893516A (zh) 用于治疗幽门螺杆菌的药物组合物
MXPA05000298A (es) Formas liquidas de dosificacion de farmacos inestables en acido.
UA81744C2 (uk) Фармацевтична композиція, що містить амінопохідну 2,3-дигідрофталазин-1,4-діону, та спосіб корекції імунної системи організму
IE45415B1 (en) Long acting preparation of cefalexin
JPH11504940A (ja) 胃腸障害の治療及び予防用のビスマス及び１以上の抗微生物剤含有組成物
US3784683A (en) Tablet preparation
JP2669818B2 (ja) 胃腸障害の治療及び予防のためのニトロフラントインの使用
Botezatu et al. Hepatic cystic echinococcosis studied in a family group
Beaty et al. Iatrogenic factors in infectious disease
US6051604A (en) Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5549911A (en) Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
CA2239423C (en) Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
JPH11504939A (ja) 胃腸障害の治療及び予防用のビスマス含有組成物
RU2152212C1 (ru) Лекарственная форма производных 5-нитроимидазола
US20230398102A1 (en) Rifaximin liquid formulations for use inthe treatment of sickle cell disease
CA2113614A1 (en) Antimicrobial treatment methods and compositions
IL30440A (en) Pharmaceutical preparation for oral administration comprising an active drug and a resin
CA2239422C (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
Wells Some aspects of parasitic disease in Vietnam returnees.
GB2233899A (en) Treating gastrointestinal infections with aztreonam